The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.00339
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Cancer Immunotherapy: Are We There Yet?

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2013English

Personalized Cancer Medicine: Are We There Yet?

Oncologist
Cancer ResearchMedicineOncology
2013English

RNAi-based Cancer Therapeutics: Are We There Yet?

Journal of Pharmacovigilance
2014English

Screening for Lung Cancer - Are We Nearly There Yet?

Trends in Urology & Men's Health
2016English

Predicting Delirium: Are We There Yet?

British Journal of Anaesthesia
AnesthesiologyPain Medicine
2017English

Clinical Proteomics: Are We There Yet?

Analytical Chemistry
Analytical Chemistry
2003English

Personalized Medicine: Are We There Yet?

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2008English

CML in India: Are We There Yet?

Indian Journal of Hematology and Blood Transfusion
Hematology
2019English

Convergence of Nanotechnology and Cancer Prevention: Are We There Yet?

Cancer Prevention Research
MedicineCancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy